← Back to Clinical Trials
Recruiting NCT06978686

NCT06978686 The Validity and Reliability of the Turkish Version of the BBAQ

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06978686
Status Recruiting
Phase
Sponsor Istanbul Medeniyet University
Condition Health Knowledge, Attitudes, Practice
Study Type OBSERVATIONAL
Enrollment 210 participants
Start Date 2025-05-20
Primary Completion 2025-06-20

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 35 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 210 participants in total. It began in 2025-05-20 with a primary completion date of 2025-06-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The Barriers to Being Active Quiz (BBAQ) was originally developed in English to identify barriers to physical activity. This study aims to translate and cross-culturally adapt the BBAQ into Turkish (BBAQ-T) and evaluate its psychometric properties.

Eligibility Criteria

Inclusion Criteria: * Aged 18 years or older * Ability to read and write in Turkish * No visual or hearing impairments that would interfere with participation * Ability to follow simple instructions * Willingness to participate in the study Exclusion Criteria: * Diagnosis of rheumatological conditions that may limit physical activity and are characterized by chronic inflammation and/or joint deformities (e.g., rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus, psoriatic arthritis) * Physical limitations due to neurological or orthopedic conditions (e.g., stroke, cerebral palsy, multiple sclerosis, limb amputation, or orthopedic surgery within the past six months) * History of psychiatric disorders that may impair cognitive functioning (e.g., schizophrenia, bipolar disorder, severe depression, attention deficit hyperactivity disorder) * Presence of any cognitive impairment

Contact & Investigator

Central Contact

EMEL METE, PhD

✉ meteemel53@gmail.com

📞 +905376096265

Frequently Asked Questions

Who can join the NCT06978686 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Health Knowledge, Attitudes, Practice. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06978686 currently recruiting?

Yes, NCT06978686 is actively recruiting participants. Contact the research team at meteemel53@gmail.com for enrollment information.

Where is the NCT06978686 trial being conducted?

This trial is being conducted at Kartal, Turkey (Türkiye), Maltepe, Turkey (Türkiye).

Who is sponsoring the NCT06978686 clinical trial?

NCT06978686 is sponsored by Istanbul Medeniyet University. The trial plans to enroll 210 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology